Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation

Heart Lung and Circulation

Volumn 23, Issue 10, 2014, Pages 957-962

  Seco, Michael ^a,b,c   Forrest, Paul ^a,c   Jackson, Simon A ^d   Martinez, Gonzalo ^c,g   Andvik, Sarah ^b   Bannon, Paul G ^a,b,c   Ng, Martin ^a,c   Fraser, John F ^e   Wilson, Michael K ^b,c,f   Vallely, Michael P ^a,b,c,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Baird Institute of Applied Heart and Lung Surgical Research   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Aortic valve; Cardiac shock; Extracorporeal membrane oxygenation; Heart valve; Percutaneous; Replacement

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA DISEASE; AORTA VALVE PROSTHESIS; AORTIC ANNULUS RUPTURE; AORTIC VALVE REPAIR; ARTERY RUPTURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMERGENCY CARE; EUROSCORE; EXTRACORPOREAL OXYGENATION; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROPHYLAXIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION; VALVULOPLASTY; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; COMPLICATION; EMERGENCY; PROPHYLACTIC SURGICAL PROCEDURE; RISK ASSESSMENT; RISK FACTOR; VENTRICULAR FIBRILLATION; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; EMERGENCIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; PROPHYLACTIC SURGICAL PROCEDURES; RISK ASSESSMENT; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; VENTRICULAR FIBRILLATION;

EID: 84907769729     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.05.006     Document Type: Article

References (16)

1. Kodali S.K., Williams M.R., Smith C.R., Svensson L.G., Webb J.G., Makkar R.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012, 366:1686-1695.
2. Kappetein A.P., Head S.J., Généreux P., Piazza N., van Mieghem N.M., Blackstone E.H., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012, 60:1438-1454.
3. Seco M., Martinez G., Bannon P.G., Cartwright B.L., Adams M., Ng M., et al. Transapical Aortic Valve Implantation-An Australian Experience. Heart. Lung and Circulation 2013.
4. Yu Y., Vallely M., Ng M.K.C. Valve-in-valve implantation for aortic annular rupture complicating transcatheter aortic valve replacement (TAVR). J Invasive Cardiol 2013, 25:409-410.
5. Vallely M.P., Wilson M.K., Adams M., Ng M.K.C. How to set up a successful TAVI program. Annals of Cardiothoracic Surgery 2012, 1:185-189.
6. Walther T., Dewey T., Borger M.A., Kempfert J., Linke A., Becht R., et al. Transapical aortic valve implantation: step by step. The Annals of Thoracic Surgery 2009, 87:276-283.
7. Clough R.E., Vallely M.P., Henein M.Y., Pepper J.R. Levitronix ventricular assist device as a bridge-to-recovery for post-cardiotomy cardiogenic shock. Int J Cardiol 2009, 134:408-409.
8. Martinez C.A., Singh V., Heldman A.W., O'Neill W.W. Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2013, 82:E128-E132.
9. Lazzeri C., Bernardo P., Sori A., Innocenti L., Stefano P., Peris A., et al. Venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a clinical challenge. Eur Heart J Acute Cardiovasc Care 2013, 2:118-126.
10. Kim H., Lim S.-H., Hong J., Hong Y.-S., Lee C.J., Jung J.-H., et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation 2012, 83:971-975.
11. Cheng R., Hachamovitch R., Kittleson M., Patel J., Arabia F., Moriguchi J., et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. The Annals of Thoracic Surgery 2014, 97:610-616.
12. Cao C., Ang S.C., Indraratna P., Manganas C., Bannon P., Black D., et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Annals of Cardiothoracic Surgery 2013, 2:10-23.
13. Husser O., Holzamer A., Philipp A., Nunez J., Bodi V., Müller T., et al. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013, 82:E542-E551.
14. Rodés-Cabau J., Webb J.G., Cheung A., Ye J., Dumont E., Feindel C.M., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
15. Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013, 382:1638-1645.
16. Drews T., Pasic M., Buz S., Dreysse S., Klein C., Kukucka M., et al. Elective use of femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation. European Journal of Cardio-Thoracic Surgery 2014.